These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31620893)
21. Ligand-field and ligand-binding analysis of the active site of copper-bound Aβ associated with Alzheimer's disease. Ghosh C; Dey SG Inorg Chem; 2013 Feb; 52(3):1318-27. PubMed ID: 23330670 [TBL] [Abstract][Full Text] [Related]
22. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes. Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646 [TBL] [Abstract][Full Text] [Related]
23. Simultaneous binding of heme and Cu with amyloid β peptides: active site and reactivities. Nath AK; Dey SG Dalton Trans; 2022 Mar; 51(13):4986-4999. PubMed ID: 35266499 [TBL] [Abstract][Full Text] [Related]
24. The amylin peptide implicated in type 2 diabetes stimulates copper-mediated carbonyl group and ascorbate radical formation. Masad A; Tabner BJ; Mayes J; Allsop D Free Radic Biol Med; 2011 Aug; 51(4):869-75. PubMed ID: 21683137 [TBL] [Abstract][Full Text] [Related]
25. Self-assembled monolayers of Aβ peptides on Au electrodes: an artificial platform for probing the reactivity of redox active metals and cofactors relevant to Alzheimer's disease. Pramanik D; Sengupta K; Mukherjee S; Dey SG; Dey A J Am Chem Soc; 2012 Jul; 134(29):12180-9. PubMed ID: 22709431 [TBL] [Abstract][Full Text] [Related]
26. Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood. Kotiya D; Leibold N; Verma N; Jicha GA; Goldstein LB; Despa F J Biol Chem; 2023 May; 299(5):104682. PubMed ID: 37030503 [TBL] [Abstract][Full Text] [Related]
27. Copper(II) and Amylin Analogues: A Complicated Relationship. Alghrably M; Dudek D; Emwas AH; Jaremko Ł; Jaremko M; Rowińska-Żyrek M Inorg Chem; 2020 Feb; 59(4):2527-2535. PubMed ID: 32027132 [TBL] [Abstract][Full Text] [Related]
28. Copper and Alzheimer's Disease. Mathys ZK; White AR Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269 [TBL] [Abstract][Full Text] [Related]
29. β-Amyloid protein (Aβ) and human amylin regulation of apoptotic genes occurs through the amylin receptor. Jhamandas JH; Mactavish D Apoptosis; 2012 Jan; 17(1):37-47. PubMed ID: 21947943 [TBL] [Abstract][Full Text] [Related]
30. Amylin deposition in the brain: A second amyloid in Alzheimer disease? Jackson K; Barisone GA; Diaz E; Jin LW; DeCarli C; Despa F Ann Neurol; 2013 Oct; 74(4):517-26. PubMed ID: 23794448 [TBL] [Abstract][Full Text] [Related]
31. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction. Furlan S; Hureau C; Faller P; La Penna G J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015 [TBL] [Abstract][Full Text] [Related]
33. Common features between diabetes mellitus and Alzheimer's disease. Götz J; Ittner LM; Lim YA Cell Mol Life Sci; 2009 Apr; 66(8):1321-5. PubMed ID: 19266159 [TBL] [Abstract][Full Text] [Related]
35. Islet amyloid polypeptide: Another key molecule in Alzheimer's pathogenesis? Zhang Y; Song W Prog Neurobiol; 2017 Jun; 153():100-120. PubMed ID: 28274676 [TBL] [Abstract][Full Text] [Related]
36. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus? Masad A; Hayes L; Tabner BJ; Turnbull S; Cooper LJ; Fullwood NJ; German MJ; Kametani F; El-Agnaf OM; Allsop D FEBS Lett; 2007 Jul; 581(18):3489-93. PubMed ID: 17617411 [TBL] [Abstract][Full Text] [Related]
37. Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats. Verma N; Ly H; Liu M; Chen J; Zhu H; Chow M; Hersh LB; Despa F J Alzheimers Dis; 2016 May; 53(1):259-72. PubMed ID: 27163815 [TBL] [Abstract][Full Text] [Related]
38. Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus. Ashraf GM; Greig NH; Khan TA; Hassan I; Tabrez S; Shakil S; Sheikh IA; Zaidi SK; Akram M; Jabir NR; Firoz CK; Naeem A; Alhazza IM; Damanhouri GA; Kamal MA CNS Neurol Disord Drug Targets; 2014; 13(7):1280-93. PubMed ID: 25230234 [TBL] [Abstract][Full Text] [Related]
39. Affinity of Cu+ for the copper-binding domain of the amyloid-β peptide of Alzheimer's disease. Feaga HA; Maduka RC; Foster MN; Szalai VA Inorg Chem; 2011 Mar; 50(5):1614-8. PubMed ID: 21280585 [TBL] [Abstract][Full Text] [Related]
40. The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease. Streltsov VA; Titmuss SJ; Epa VC; Barnham KJ; Masters CL; Varghese JN Biophys J; 2008 Oct; 95(7):3447-56. PubMed ID: 18599641 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]